Dr. Katherine Luzuriaga, a vice provost at UMass Medical School and the director of its Center for Clinical and Translational Science, is a candidate to lead the U.S. Food and Drug Administration.
Hispanic and Black patients represented a disproportionate share of COVID-19 hospitalizations in 2020, as did patients from lower-income communities, according to a new state report.
The Massachusetts Health Policy Commission will not conduct a detailed review of market costs for a proposed merger between UMass Memorial Health and Harrington Hospital, based on preliminary findings the deal isn't likely to lead to additional costs for patients.
Long-term care facilities are starting to see long-awaited signs of post-pandemic life, with residents and staff largely vaccinated and loosened state restrictions now allowing for some gatherings and in-person visits from family.
Marlborough medical device manufacturer Hologic has agreed to acquire the Finnish-French company Mobidiag Oy for $795 million, Hologic announced on Thursday.
A week ahead of the House's expected fiscal year 2022 budget reveal, the Baker administration said it has worked up new spending projections for the single largest budget item to account for a federal-level change that could drive up costs by more than $1.4 billion while providing additional revenue to offset most or all of the extra spending.
Heywood Healthcare was profitable in its 2020 budget year, while most other Central Massachusetts hospital networks ran deficits despite federal coronavirus pandemic relief funding.